Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8509)
All Articles published online
|
Publishing Process of This Article
|
Oct 28, 2015 (publication date) through May 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Walayat S, Ahmed Z, Martin D, Puli S, Cashman M, Dhillon S. Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine. World J Hepatol 2015; 7(24): 2503-2509 [PMID: 26523203 DOI: 10.4254/wjh.v7.i24.2503] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i24/2503.htm |
| Number | Citing Articles |
| 1 |
Corey Saraceni, John Birk. A Review of Hepatitis B Virus and Hepatitis C Virus Immunopathogenesis. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00095
|
| 2 |
Jingling Tian, Fang Tan, Lifei Lai, Yingqing Deng, Xinjin Chi, Hongfang Geng, Qianqian Zhu. Anesthesiologists’ acquisition of hepatitis B virus infection. Medicine 2019; 98(29): e16416 doi: 10.1097/MD.0000000000016416
|
| 3 |
Maria Ganczak, Marcin Korzen, Alina Jurewicz, Zbigniew Szych. A cross-sectional sero-survey on preoperative HBV vaccination policy in Poland. BMC Infectious Diseases 2017; 17(1) doi: 10.1186/s12879-017-2607-2
|
| 4 |
FarinaM Hanif, Nasir Mehmood, Zain Majid, NasirH Luck, SMudassir Laeeq, AbbasA Tasneem, MuhammadManzoor ul Haque. Successful response of intradermal hepatitis B vaccine in nonresponders of intramuscular hepatitis B vaccine in general and hemodialysis population. Saudi Journal of Gastroenterology 2020; 26(6): 306 doi: 10.4103/sjg.SJG_300_20
|
| 5 |
Said A. Al-Busafi, Ahmed Alwassief. Global Perspectives on the Hepatitis B Vaccination: Challenges, Achievements, and the Road to Elimination by 2030. Vaccines 2024; 12(3): 288 doi: 10.3390/vaccines12030288
|
| 6 |
Elaheh Gholami Parizad, Abbas Ali Imani Fooladi, Hamid Sedighian, Elham Behzadi, Jafar Amani, Afra Khosravi. Immune response induced by recombinant pres2/S-protein and a pres2-S-protein fused with a core 18-27 antigen fragment of hepatitis B virus compared to conventional HBV vaccine. Virus Genes 2023; 59(4): 499 doi: 10.1007/s11262-023-01995-z
|
| 7 |
Senoo-Dogbey Vivian Efua, Wuaku Delali Adwoa, Mumuni Adiza Atoko. Adherence to the three-component Hepatitis B virus vaccination protocol among healthcare workers in hepatitis B virus endemic settings in Ghana. Vaccine: X 2024; 16: 100421 doi: 10.1016/j.jvacx.2023.100421
|
| 8 |
Faye V. Andrews, Ellen Smit, Barrett M. Welch, Sharia M. Ahmed, Molly L. Kile. Urinary polycyclic aromatic hydrocarbons concentrations and hepatitis B antibody serology in the United States (NHANES, 2003–2014). Environmental Research 2021; 195: 110801 doi: 10.1016/j.envres.2021.110801
|
| 9 |
Sanjit Boora, Vikrant Sharma, Sulochana Kaushik, Ajoy Varma Bhupatiraju, Sandeep Singh, Samander Kaushik. Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem. Brazilian Journal of Microbiology 2023; 54(2): 679 doi: 10.1007/s42770-023-00970-y
|
| 10 |
Cândida Abreu, António Sarmento, Fernando Magro. Screening, prophylaxis and counselling before the start of biological therapies: A practical approach focused on IBD patients. Digestive and Liver Disease 2017; 49(12): 1289 doi: 10.1016/j.dld.2017.09.002
|
| 11 |
Negin Rahmani, Afagh Moattari, Neda Pirbonyeh, Vida Keshavarzi, Golnoush Sadat Mahmoudi Nezhad. Immunity to Measles, Rubella, and Hepatitis B Viruses Among Students of Shiraz University of Medical Sciences, Iran: A Cross-Sectional Study. Zahedan Journal of Research in Medical Sciences 2019; 21(3) doi: 10.5812/zjrms.86972
|
| 12 |
Ozlem Equils, Angela Bakaj, Brittany Wilson-Mifsud, Archana Chatterjee. Restoring Trust: The Need for Precision Medicine in Infectious Diseases, Public Health and Vaccines. Human Vaccines & Immunotherapeutics 2023; 19(2) doi: 10.1080/21645515.2023.2234787
|
| 13 |
Magda Rybicka, Krzysztof Piotr Bielawski. Recent Advances in Understanding, Diagnosing, and Treating Hepatitis B Virus Infection. Microorganisms 2020; 8(9): 1416 doi: 10.3390/microorganisms8091416
|
| 14 |
Timo Vesikari, Joanne M Langley, Vlad Popovic, Francisco Diaz-Mitoma. PreHevbrio: the first approved 3-antigen hepatitis B vaccine. Expert Review of Vaccines 2023; 22(1): 1041 doi: 10.1080/14760584.2023.2274482
|
| 15 |
Agnieszka Piekarska, Piotr Wisniewski, Krzysztof Lewandowski, Lidia Gil, Piotr Trzonkowski, Maria Bieniaszewska, Jan Maciej Zaucha. Immune Status Against Hepatitis B in Patients After Allogeneic Hematopoietic Cell Transplantation—Factors Affecting Early and Long-Lasting Maintenance of Protective Anti-HBs Titers. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.586523
|
| 16 |
Robério Amorim de Almeida Pondé. Expression and detection of anti-HBs antibodies after hepatitis B virus infection or vaccination in the context of protective immunity. Archives of Virology 2019; 164(11): 2645 doi: 10.1007/s00705-019-04369-9
|
| 17 |
Ji Young Chang, Sung-Ae Jung, Chang Mo Moon, Seong-Eun Kim, Hye-Kyung Jung, Ki-Nam Shim. Response to hepatitis B vaccination in patients with inflammatory bowel disease: a prospective observational study in Korea. Intestinal Research 2018; 16(4): 599 doi: 10.5217/ir.2018.00012
|
| 18 |
Ming-Ju Zhou, Chao Zhang, Yuan-Jie Fu, Haiyan Wang, Yingjie Ji, Xia Huang, Lin Li, Ye Wang, Song Qing, Yanze Shi, Lili Shen, You-Yuan Wang, Xiao-Yu Li, Yuan-Yuan Li, Si-Yuan Chen, Cheng Zhen, Ruonan Xu, Ming Shi, Fu-Sheng Wang, Yongqian Cheng. Cured HCV patients with suboptimal hepatitis B vaccine response exhibit high self-reactive immune signatures. Hepatology Communications 2023; 7(7) doi: 10.1097/HC9.0000000000000197
|
| 19 |
Sean Lipsit, Antonio Facciuolo, Erin Scruten, Philip Griebel, Scott Napper. Plasma Cytokines and Birth Weight as Biomarkers of Vaccine-Induced Humoral Responses in Piglets. Frontiers in Veterinary Science 2022; 9 doi: 10.3389/fvets.2022.922992
|
| 20 |
R Jayaprada, N Ramakrishna, B Vasavi, B Venkataramana, KK Sharma. Evaluation of hepatitis B vaccination status and immune response among clinicians in a tertiary care hospital in South India. Journal of Clinical and Scientific Research 2019; 8(2): 74 doi: 10.4103/JCSR.JCSR_52_19
|
| 21 |
Mohammed Ali Bakkari, Sivakumar S. Moni, Abdulrahman Alshammari, Muhammad H. Sultan, Osama A. Madkhali, Yosif Almoshari, Mohammad Firoz Alam, Mohamed Eltaib Elmobark. Induction of Innate and Adaptive Immune Response against Recombinant HBsAg Protein Entrapped in Docosahexaenoic Acid Nanovesicles through Biomarkers. Vaccines 2023; 11(2): 457 doi: 10.3390/vaccines11020457
|
| 22 |
A. Boyd, J. Gozlan, F. Carrat, H. Rougier, P.-M. Girard, K. Lacombe, J. Bottero. Self-reported patient history to assess hepatitis B virus serological status during a large screening campaign. Epidemiology and Infection 2019; 147 doi: 10.1017/S0950268818002650
|
| 23 |
Roshell Muir, Talibah Metcalf, Slim Fourati, Yannic Bartsch, Jacqueline Kyosiimire-Lugemwa, Glenda Canderan, Galit Alter, Enoch Muyanja, Brenda Okech, Teddy Namatovu, Irene Namara, Annemarie Namuniina, Ali Ssetaala, Juliet Mpendo, Annet Nanvubya, Paul Kato Kitandwe, Bernard S. Bagaya, Noah Kiwanuka, Jacent Nassuna, Victoria Menya Biribawa, Alison M. Elliott, Claudia J. de Dood, William Senyonga, Priscilla Balungi, Pontiano Kaleebu, Yunia Mayanja, Matthew Odongo, Jennifer Connors, Pat Fast, Matt A. Price, Paul L. A. M. Corstjens, Govert J. van Dam, Anatoli Kamali, Rafick Pierre Sekaly, Elias K. Haddad, Krystyna Cwiklinski. Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responses. PLOS Neglected Tropical Diseases 2023; 17(7): e0011089 doi: 10.1371/journal.pntd.0011089
|
| 24 |
Eugene M. Tan, Jasmine R. Marcelin, Abinash Virk. Pre-travel counseling for immunocompromised travelers: A 12-year single-center retrospective review. Infection, Disease & Health 2019; 24(1): 13 doi: 10.1016/j.idh.2018.09.083
|
| 25 |
María B Pisano, Cecilia G Giadans, Diego M Flichman, Viviana E Ré, María V Preciado, Pamela Valva. Viral hepatitis update: Progress and perspectives . World Journal of Gastroenterology 2021; 27(26): 4018-4044 doi: 10.3748/wjg.v27.i26.4018
|
| 26 |
Özgür M. Koc, Eva van Oorschot, Lloyd Brandts, Astrid Oude Lashof. Timing of primary three‐dose hepatitis B vaccination and postvaccination serologic testing among a large cohort of healthy adults. Journal of Medical Virology 2022; 94(9): 4433 doi: 10.1002/jmv.27848
|
| 27 |
Guglielmo Borgia, Alberto Enrico Maraolo, Ivan Gentile. Hepatitis B mother-to-child transmission and infants immunization: we have not come to the end of the story yet. Infectious Diseases 2017; 49(8): 584 doi: 10.1080/23744235.2017.1303746
|
| 28 |
Neslihan Kayraklioglu, Begum Horuluoglu, Dennis M. Klinman. DNA Vaccines. Methods in Molecular Biology 2021; 2197: 51 doi: 10.1007/978-1-0716-0872-2_4
|
| 29 |
José L. Bravo-Grande, M. Asunción Blanco-González, José M. de la Torre-Robles, Marita P. Asmat-Inostrosa, Marina Fernández-Escribano, Itria Mirabella Villalobos, M. Covadonga Caso-Pita, Marina Hervella-Ordoñez, Luis M. Cañibano Cimas, José M. de la Fuente-Martín, M. Luisa Rodríguez de la Pinta, Jenry Ricardo Borda Olivas, Carmen Muñóz-Ruipérez, Miguel A. Alonso López, MT del Campo, M. Antonieta Ramírez Pérez, Ignacio Sánchez-Arcilla, Marco Marzola-Payares, Fernando Rescalvo-Santiago, Miguel de Paula-Ortiz, José M. Sánchez-Santos, Ricardo López-Pérez. Vaccination adjuvated against hepatitis B in Spanish National Healthcare System (SNS) workers typed as non-responders to conventional vaccines. Vaccine 2021; 39(3): 554 doi: 10.1016/j.vaccine.2020.12.006
|
| 30 |
Ashraf Elbahrawy, Hassan Atalla, Mohamed Alboraie, Ahmed Alwassief, Ali Madian, Mohammed El Fayoumie, Ashraf A. Tabll, Hussein H. Aly. Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review. Viruses 2023; 15(1): 214 doi: 10.3390/v15010214
|
| 31 |
Kang Fang, Yingying Shi, Zeyu zhao, Yunkang Zhao, Yichao Guo, Buasivamu Abudunaibi, Huimin Qu, Qiao Liu, Guodong Kang, Zhiguo Wang, Jianli Hu, Tianmu Chen. Trends in disease burden of hepatitis B infection in Jiangsu Province, China, 1990–2021. Infectious Disease Modelling 2023; 8(3): 832 doi: 10.1016/j.idm.2023.07.007
|
| 32 |
Isabela Cristina RODRIGUES, Rita de Cássia Martins Alves da SILVA, Helen Catharine Camarero de FELÍCIO, Renato Ferreira da SILVA. NEW IMMUNIZATION SCHEDULE EFFECTIVENESS AGAINST HEPATITIS B IN LIVER TRANSPLANTATION PATIENTS. Arquivos de Gastroenterologia 2019; 56(4): 440 doi: 10.1590/s0004-2803.201900000-77
|
| 33 |
Thalia Ash, Lester Mascarenhas, John Furler, Meredith Temple-Smith. Hepatitis B contact tracing: what works?. Australian Journal of Primary Health 2018; 24(6): 470 doi: 10.1071/PY17087
|
| 34 |
Senoo-Dogbey Vivian Efua, Deborah Armah, Wuaku Delali Adwoa. Hepatitis B virus vaccination post serological testing and antibody levels of vaccinated health care workers in Accra, Ghana. Vaccine: X 2023; 14: 100294 doi: 10.1016/j.jvacx.2023.100294
|
| 35 |
Tara Vinyette Saco, Alexandra T. Strauss, Dennis K. Ledford. Hepatitis B vaccine nonresponders. Annals of Allergy, Asthma & Immunology 2018; 121(3): 320 doi: 10.1016/j.anai.2018.03.017
|
| 36 |
Zhi-Biao Wang, Pu Shan, Su-Zhen Li, Ya Zhou, Xia Deng, Ji-Lai Li, Yu Zhang, Jin-Shuang Gao, Jing Xu. The mechanism of action of acid-soluble chitosan as an adjuvant in the formulation of nasally administered vaccine against HBV. RSC Advances 2016; 6(99): 96785 doi: 10.1039/C6RA14419E
|
| 37 |
Raffaella Mormile. Hepatitis B vaccine non response: A predictor of latent autoimmunity?. Medical Hypotheses 2017; 104: 45 doi: 10.1016/j.mehy.2017.05.020
|
| 38 |
Guan-Huei Lee, Seng-Gee Lim. CpG-Adjuvanted Hepatitis B Vaccine (HEPLISAV-B®) Update. Expert Review of Vaccines 2021; 20(5): 487 doi: 10.1080/14760584.2021.1908133
|
| 39 |
Alessandro Godono, Marco Clari, Riccardo Corgiat Loia, Bruna Panero, Samuele Noè, Elisa Carena, Ihab Mansour, Valerio Dimonte, Enrico Pira, Lorena Charrier. Serosusceptibility and hesitancy for booster HBV vaccination among health care workers in Italy: a cross-sectional study.. Journal of Infection and Public Health 2024; doi: 10.1016/j.jiph.2024.04.011
|
| 40 |
S. N. Kuzin, T. A. Semenenko, V. V. Klushkina, N. V. Vlasenko, N. S. Churilova, Ya. V. Panasyuk, E. N. Kudryavtseva, M. I. Korabel'nikova, D. V. Dubodelov, Z. S. Rodionova, G. G. Solopova, M. V. Konopliova, I. G. Nikitin, N. I. Shulakova, A. V. Tutelian, V. G. Akimkin. Herd Immunity to Hepatitis B in the Russian Federation in 2017–2019. Epidemiology and Vaccinal Prevention 2022; 21(2): 29 doi: 10.31631/2073-3046-2022-21-2-29-37
|
| 41 |
Özgür M. Koc, Philippe de Smedt, Cécile Kremer, Geert Robaeys, Pierre van Damme, Niel Hens, Jorge Almeida, Frank Falkenberg, Paul Savelkoul, Astrid Oude Lashof. Immunogenicity and safety of HBAI20 Hepatitis B vaccine in non‐responders: Double‐blinded, randomised, controlled phase 2 trial. Liver International 2021; 41(10): 2318 doi: 10.1111/liv.14939
|
| 42 |
Lucile Dumolard, Caroline Aspord, Patrice N. Marche, Zuzana Macek Jilkova. Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1148111
|
| 43 |
Kana Shiraishi, Osamu Yoshida, Yusuke Imai, Sheikh Akbar, Takahiro Sanada, Michinori Kohara, Takashi Miyazaki, Taizou Kamishita, Teruki Miyake, Masashi Hirooka, Yoshio Tokumoto, Masanori Abe, Julio Rubido, Gerardo Nieto, Yoichi Hiasa. Intranasal HBsAg/HBcAg-Containing Vaccine Induces Neutralizing Anti-HBs Production in Hepatitis B Vaccine Non-Responders. Vaccines 2023; 11(9): 1479 doi: 10.3390/vaccines11091479
|
| 44 |
Özgür M Koc, Jan Damoiseaux, Inge H.M. van Loo, Heloise I.L. Masquillier, Astrid M.L. Oude Lashof. Case report of delayed seroprotection rather than non-response after primary three-dose hepatitis B vaccination. Vaccine 2020; 38(2): 112 doi: 10.1016/j.vaccine.2019.10.022
|
| 45 |
Seyed Mohammad Ali Hashemi, Fatemeh Hashemzadeh, Helen Bahrampour, Fatemeh Nekoei, Negar Joharinia, Jamal Sarvari. The evaluation anti-HBsAb titer among university students in Shiraz, 2019. Iranian Journal of Medical Microbiology 2020; 14(4): 297 doi: 10.30699/ijmm.14.4.297
|
| 46 |
Ioanna Aggeletopoulou, Panagiota Davoulou, Christos Konstantakis, Konstantinos Thomopoulos, Christos Triantos. Response to hepatitis B vaccination in patients with liver cirrhosis. Reviews in Medical Virology 2017; 27(6) doi: 10.1002/rmv.1942
|
| 47 |
Kousar Smailnejad-Ganji, Mousa Mohammadnia-Afrouzi, Iraj Mohammad-Zadeh, Mojdeh Ghias Tabari, Azam Bolhassani, Zahra Moulana, Mojgan Bagherzadeh, Mehdi Shahbazi. Relationship Between HBsAb Response, Expression of TLR 2, 3 and 4, and Birth Season in 3 - 5-Year-Old Children. Jundishapur Journal of Microbiology 2019; 12(8) doi: 10.5812/jjm.91649
|
| 48 |
Stephen C. Pappas. Hepatitis B and Health Care Workers. Clinics in Liver Disease 2021; 25(4): 859 doi: 10.1016/j.cld.2021.06.010
|
| 49 |
M. Alanko Blomé, P. Björkman, L. Flamholc, H. Jacobsson, A. Widell. Vaccination against hepatitis B virus among people who inject drugs – A 20year experience from a Swedish needle exchange program. Vaccine 2017; 35(1): 84 doi: 10.1016/j.vaccine.2016.11.041
|
| 50 |
Francesco P. Bianchi, Maria S. Gallone, Maria F. Gallone, Angela M. V. Larocca, Luigi Vimercati, Michele Quarto, Silvio Tafuri. HBV seroprevalence after 25 years of universal mass vaccination and management of non‐responders to the anti‐Hepatitis B vaccine: An Italian study among medical students. Journal of Viral Hepatitis 2019; 26(1): 136 doi: 10.1111/jvh.13001
|
| 51 |
Alan J. Wigg, Rachel Wundke, Rosemary McCormick, Kate R. Muller, Jeyamani Ramachandran, Sumudu K. Narayana, Richard J. Woodman. Efficacy of High-Dose, Rapid, Hepatitis A and B Vaccination Schedules in Patients With Cirrhosis. Clinical Gastroenterology and Hepatology 2019; 17(6): 1210 doi: 10.1016/j.cgh.2018.08.047
|
| 52 |
Congcong Zhang, Rina M. Ötjengerdes, Julian Roewe, Rebeca Mejias, Andrea L. J. Marschall. Applying Antibodies Inside Cells: Principles and Recent Advances in Neurobiology, Virology and Oncology. BioDrugs 2020; 34(4): 435 doi: 10.1007/s40259-020-00419-w
|
| 53 |
Dolvy Girawan, Raden T. D. Judistiani, Nelly A. Risan, Muhammad B. Bestari, Eka S. Nugraha, Yudith S. Ermaya, Dwi Prasetyo, Dirk Uhlmann. The High Prevalence of Negative Hepatitis B Surface Antibody (Anti-HBs) among Pregnant Women in Bandung, Indonesia: A Community-Based Study. International Journal of Hepatology 2020; 2020: 1 doi: 10.1155/2020/3414869
|
| 54 |
Marc A. Meier, Christoph T. Berger. A simple clinical score to identify likely hepatitis B vaccination non-responders – data from a retrospective single center study. BMC Infectious Diseases 2020; 20(1) doi: 10.1186/s12879-020-05634-y
|
| 55 |
Jasna Omersel, Nataša Karas Kuželički. Vaccinomics and Adversomics in the Era of Precision Medicine: A Review Based on HBV, MMR, HPV, and COVID-19 Vaccines. Journal of Clinical Medicine 2020; 9(11): 3561 doi: 10.3390/jcm9113561
|
| 56 |
Abdullah Ely, Prashika Singh, Tiffany S. Smith, Patrick Arbuthnot. In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infection. Advanced Drug Delivery Reviews 2021; 168: 134 doi: 10.1016/j.addr.2020.05.010
|
| 57 |
Yu-Liang Zhao, Bi-Hua Han, Xin-Jiang Zhang, Lu-Lu Pan, Hai-Song Zhou, Zhao Gao, Zhi-Yong Hao, Zhi-Wei Wu, Tian-Li Ma, Feng Wang, Qi Li, Sheng-Li Bi, Jing-Chen Ma. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4134-9
|
| 58 |
Vivian Efua Senoo-Dogbey, Lillian Akorfa Ohene, Delali Adwoa Wuaku. Occupational exposure to Hepatitis B virus, disease burden and pathways for postexposure prophylaxis management: recommendations for healthcare workers in highly endemic settings. Infection Prevention in Practice 2024; 6(2): 100354 doi: 10.1016/j.infpip.2024.100354
|
| 59 |
Rahul Gupta, Ibukun Fakunle, Varun Samji, Elizabeth B Hale. Serum Sickness-Like Reaction Associated With Acute Hepatitis B in a Previously Vaccinated Adult Male. Cureus 2021; doi: 10.7759/cureus.14742
|
| 60 |
Babayemi O. Olakunde, Ijeoma M. Ifeorah, Daniel A. Adeyinka, Olubunmi A. Olakunde, Temitayo Ogundipe, John O. Olawepo, Echezona E. Ezeanolue. Immune response to hepatitis B vaccine among children under 5 years in Africa: a meta-analysis. Tropical Medicine and Health 2024; 52(1) doi: 10.1186/s41182-024-00594-4
|
| 61 |
Manjusha Das, Vishwas Vanar, Daniel K. Martin, Saqib Walayat, Jaymon Patel, Maaz B. Badshah, Nikhil R. Kalva, Watcoun-Nchinda Pisoh, Sonu Dhillon. Seroconverting nonresponder of high-dose intramuscular HBV vaccine with intradermal HBV vaccine. Medicine 2017; 96(46): e8575 doi: 10.1097/MD.0000000000008575
|
| 62 |
Vivian Efua Senoo-Dogbey, Francis Anto, Reginald Quansah, Anthony Danso-Appiah, Stephen Dajaan Dubik. Completion of three-dose hepatitis B vaccination cycle and associated factors among health care workers in the Greater Accra Region of Ghana. PLOS ONE 2024; 19(4): e0298771 doi: 10.1371/journal.pone.0298771
|
| 63 |
Reem A. Shalabi, Michelle A. Worst, Thomas E. Hughes, Tracey Walsh‐Chocolaad, Lisa Cook, Kristen Gunn, Brian Wells, Rodica Ciurea, Georg Aue, Xin Tian, Richard W. Childs. Haematopoietic stem cell transplant patients have a high initial failure rate to hepatitis B vaccination that can be overcome with subsequent vaccination series. British Journal of Haematology 2022; 196(6): 1404 doi: 10.1111/bjh.17991
|
| 64 |
Mario Rivera-Izquierdo, Maria del Carmen Valero-Ubierna, Pelayo Nieto-Gómez, María Dolores Martínez-Bellón, Nicolás Francisco Fernández-Martínez, José Luis Barranco-Quintana. Vaccination in patients under monoclonal antibody treatment: an updated comprehensive review. Expert Review of Vaccines 2020; 19(8): 727 doi: 10.1080/14760584.2020.1800462
|
| 65 |
Jingying Qiu, Bixue Xu, Qineng Gong, Weidong Pan, Changxiao Liu, Zhengming Huang, Xiaoke Gu, Guangyi Liang. Synthesis and Biological Evaluation of Matijin‐Su Derivatives as Potential Antihepatitis B Virus and Anticancer Agents. Chemistry & Biodiversity 2016; 13(11): 1584 doi: 10.1002/cbdv.201600113
|
| 66 |
Fahad Muwanda, Hakim Sendagire, Gerald Mboowa, David Patrick Kateete, Beatrice Achan, Ezekiel Mupere, Hussein Mukasa Kafeero, Bernard Ssentalo Bagaya. A systematic review reveals that African children of 15–17 years demonstrate low hepatitis B vaccine seroprotection rates. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-49674-1
|
| 67 |
Oguz Karabay, Gamze Guney Eskiler, Umut Alkurt, Kaan Furkan Hamarat, Asuman Deveci Ozkan, Ayhan Aydin. The predictive role of NF-κB-mediated pro-inflammatory cytokine expression levels in hepatitis B vaccine response. Journal of Immunoassay and Immunochemistry 2023; 44(2): 192 doi: 10.1080/15321819.2022.2164507
|
| 68 |
Mohammed Ali Bakkari, Sivakumar S. Moni, Abdulrahman Alshammari, Ahmad Salawi, Muhammad H. Sultan, Osama A. Madkhali, Saad S. Alqahtani, Mohammad Firoz Alam, Emad Sayed Shaheen, Mohamed Eltaib Elmobark. Design, Characterization, and Immune Augmentation of Docosahexaenoic Acid Nanovesicles as a Potential Delivery System for Recombinant HBsAg Protein. Vaccines 2022; 10(6): 954 doi: 10.3390/vaccines10060954
|
| 69 |
Antonio Toniolo, Gianluca Cassani, Anna Puggioni, Agostino Rossi, Alberto Colombo, Takashi Onodera, Ele Ferrannini. The diabetes pandemic and associated infections: suggestions for clinical microbiology. Reviews in Medical Microbiology 2019; 30(1): 1 doi: 10.1097/MRM.0000000000000155
|
| 70 |
Stephen G. Holt, Stephen Locarnini, Joe Sasadeusz. Hepatitis B related dilemmas in the renal unit. Nephrology 2021; 26(4): 287 doi: 10.1111/nep.13815
|